CERo Therapeutics, Inc. Appoints Chris Ehrlich CEO
06 déc. 2024 09h00 HE
|
CERo Therapeutics Holdings, Inc.
SOUTH SAN FRANCISCO, Calif, Dec. 06, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next generation...